Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
www.ahrq.gov

2008 State Snapshots Home
Getting Started
State Selection Map
What's New
State-Specific Information
State Dashboard
Overall Health Care Quality
Strongest and Weakest Measures
Types of Care
Settings of Care
Care by Clinical Area
Focus on Diabetes
 Prevalence
 Quality of Care
 
Quality Improvement
  
Lives and Expenses
  Excess Costs of Diabetes
 Disparities in Treatment
Focus on Asthma
Focus on Healthy People 2010
Focus on Clinical Preventive Services
Focus on Disparities
State Rankings for Selected Measures
Contextual Factors
Other Information
All-State Data Tables for All Measures
Snapshot Print Version
Other State Snapshot Years
Step-by-Step User's Guide
Interpretation of Results
Methods
Technical Assistance

Related Links
Measuring Healthcare Quality
Health Care Report Card Compendium
 

New York

Focus on Diabetes:

Disparities in Treatment: HbA1c Testing for Blacks, Hispanics, and Whites

For a few States, racial/ethnic groups also can be evaluated for HbA1c monitoring. When sufficient data are available, the maps below show whether the gap in the rate of HbA1c testing among different racial groups and Whites within a State is worse than, similar to, or better than the gap that exists across all States with data. The bar chart shows the actual percentage of people with diabetes in racial and ethnic groups who receive HbA1c monitoring in the State (if available), in the region, and in all States.


For 2005-2007, The Gap in HbA1c Testing for People with Diabetes for Non-Hispanic Blacks Compared to Non-Hispanic Whites.

For 2005-2007, The Gap in HbA1c Testing for People with Diabetes for Non-Hispanic Blacks Compared to Non-Hispanic Whites.


HbA1c monitoring uses a blood test that indicates to a health care provider how well a patient's diabetes has been controlled. It is an important test that helps providers monitor and guide patients to minimize and avoid serious complications. In the map above:

  • Worse than the all-State gap means the gap in HbA1c testing between non-Hispanic Black people with diabetes and non-Hispanic White people with diabetes is worse than the gap between these groups across all States with data.
  • Similar to the all-State gap means the gap in HbA1c testing between non-Hispanic Black people with diabetes and non-Hispanic White people with diabetes is similar to the gap between these groups across all States with data.
  • Better than the all-State gap means the gap in HbA1c testing between non-Hispanic Black people with diabetes and non-Hispanic White people with diabetes is better than the gap between these groups across all States with data.
  • Unknown/data insufficient means a measure for the State could not be made.
For 2005-2007, The Gap in HbA1c Testing for People with Diabetes for Non-Hispanic Blacks Compared to Non-Hispanic Whites. The gap is worse than the all-State gap in the following States: Colorado, New Jersey, and Oklahoma. The gap is similar to the all-State gap in the following States: Arkansas, Connecticut, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Mississippi, Missouri, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, and Washington. The gap is better than the all-State gap in the following States: Alabama, California, Indiana, Michigan, and Wisconsin. There is insufficient data for these States: Alaska, Arizona, Hawaii, Idaho, Illinois, Iowa, Kansas, Maine, Maryland, Massachusetts, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, West Virginia, and Wyoming.

These categories are based on comparisons of the relative rates of HbA1c testing for people with diabetes within the two race/ethnicity groups in each State relative to the all-State rates for those race/ethnicity groups, for the period 2002–2004. Data are from the Behavioral Risk Factor Surveillance System. For more information, select Methods.


For 2005-2007, The Gap in HbA1c Testing for People with Diabetes for Hispanics Compared to Non-Hispanic Whites.

For 2005-2007, The Gap in HbA1c Testing for People with Diabetes for Hispanics Compared to Non-Hispanic Whites.

HbA1c monitoring uses a blood test that indicates to a health care provider how well a patient's diabetes has been controlled. It is an important test that helps providers monitor and guide patients to minimize and avoid serious complications. In the map above:

  • Worse than the all-State gap means the gap in HbA1c testing between Hispanic people with diabetes and non-Hispanic White people with diabetes is worse than the gap between these groups across all States with data.
  • Similar to the all-State gap means the gap in HbA1c testing between Hispanic people with diabetes and non-Hispanic White people with diabetes is similar to the gap between these groups across all States with data.
  • Better than the all-State gap means the gap in HbA1c testing between Hispanic people with diabetes and non-Hispanic White people with diabetes is better than the gap between these groups across all States with data.
  • Unknown/data insufficient means a measure for the State could not be made.
For 2005-2007, The Gap in HbA1c Testing for People with Diabetes for Hispanics Compared to Non-Hispanic Whites. The gap is worse than the all-State gap in the following States: Arizona, Connecticut, Florida, Idaho, New Jersey, North Carolina, South Carolina, and Utah. The gap is similar to the all-State gap in the following States: Arkansas, Colorado, Indiana, Louisiana, Nevada, New York, Texas, and Washington. The gap is better than the all-State gap in the following States: California, Georgia, Hawaii, New Mexico, Pennsylvania, and Wyoming. There is insufficient data for these States: Alabama, Alaska, Delaware, District of Columbia, Illinois, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Dakota, Tennessee, Vermont, Virginia, West Virginia, and Wisconsin.

These categories are based on comparisons of the relative rates of HbA1c testing for people with diabetes within the two race/ethnicity groups in each State relative to the all-State rates for those race/ethnicity groups, for the period 2002–2004. Data are from the Behavioral Risk Factor Surveillance System. For more information, select Methods.

The chart below shows the actual rates of HbA1c monitoring for people who are non-Hispanic Black, Hispanic, or non-Hispanic White within the State, the region, and all States. Any missing bars reflect insufficient data for a group within the State.

Percent of People in New York With Diabetes Who Had an HbA1c Test, by Race/Ethnicity, 2005 to 2007.

Percent of People in New York With Diabetes Who Had an HbA1c Test, by Race/Ethnicity, 2005 to 2007.
Percent of People in New York With Diabetes Who Had an HbA1c Test, by Race/Ethnicity, 2005 to 2007. Bar chart. For Non-Hispanic Blacks, the percentage in New York is 89.1; the percentage in the Middle Atlantic States is 87.5; and the percentage in all States is 88.4. For Hispanics, the percentage in New York is 87.4; the percentage in the Middle Atlantic States is 84.4; and the percentage in all States is 81.8. For Non-Hispanic Whites, the percentage in New York is 94.2; the percentage in the Middle Atlantic States is 93.0; and the percentage in all States is 90.1.

The bar chart represents the percent of people with diabetes who had an HbA1c test in the previous 12 months for the period 2002–2004. Data are from the Behavioral Risk Factor Surveillance System. For more information, select Methods.